Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis

2000 ◽  
Vol 26 (9) ◽  
pp. 1360-1363 ◽  
Author(s):  
A. Tennilä ◽  
T. Salmi ◽  
V. Pettilä ◽  
R.O. Roine ◽  
T. Varpula ◽  
...  
2014 ◽  
Vol 32 (11) ◽  
pp. 1319-1325 ◽  
Author(s):  
Michael M. Liao ◽  
Dennis Lezotte ◽  
Steven R. Lowenstein ◽  
Kevin Howard ◽  
Zachary Finley ◽  
...  

2021 ◽  
Vol 8 ◽  
Author(s):  
Siyi Yuan ◽  
Yunbo Sun ◽  
Xiongjian Xiao ◽  
Yun Long ◽  
Huaiwu He

Background: Distinguishing ICU patients with candidaemia can help with the precise prescription of antifungal drugs to create personalized guidelines. Previous prediction models of candidaemia have primarily used traditional logistic models and had some limitations. In this study, we developed a machine learning algorithm trained to predict candidaemia in patients with new-onset systemic inflammatory response syndrome (SIRS).Methods: This retrospective, observational study used clinical information collected between January 2013 and December 2017 from three hospitals. The ICU patient data were used to train 4 machine learning algorithms–XGBoost, Support Vector Machine (SVM), Random Forest (RF), ExtraTrees (ET)–and a logistic regression (LR) model to predict patients with candidaemia.Results: Of the 8,002 cases of new-onset SIRS (in 7,932 patients) included in the analysis, 137 new-onset SIRS cases (in 137 patients) were blood culture positive for candidaemia. Risk factors, such as fungal colonization, diabetes, acute kidney injury, the total number of parenteral nutrition days and renal replacement therapy, were important predictors of candidaemia. The XGBoost machine learning model outperformed the other models in distinguishing patients with candidaemia [XGBoost vs. SVM vs. RF vs. ET vs. LR; area under the curve (AUC): 0.92 vs. 0.86 vs. 0.91 vs. 0.90 vs. 0.52, respectively]. The XGBoost model had a sensitivity of 84%, specificity of 89% and negative predictive value of 99.6% at the best cut-off value.Conclusions: Machine learning algorithms can potentially predict candidaemia in the ICU and have better efficiency than previous models. These prediction models can be used to guide antifungal treatment for ICU patients when SIRS occurs.


2009 ◽  
Vol 17 (3) ◽  
pp. 447-453 ◽  
Author(s):  
Alex Smithson ◽  
Rafael Perello ◽  
Jesus Aibar ◽  
Gerard Espinosa ◽  
Dolors Tassies ◽  
...  

ABSTRACT Gene polymorphisms, giving rise to low serum levels of mannose-binding lectin (MBL) or MBL-associated protease 2 (MASP2), have been associated with an increased risk of infections. The objective of this study was to assess the outcome of intensive care unit (ICU) patients with systemic inflammatory response syndrome (SIRS) regarding the existence of functionally relevant MBL2 and MASP2 gene polymorphisms. The study included 243 ICU patients with SIRS admitted to our hospital, as well as 104 healthy control subjects. MBL2 and MASP2 single nucleotide polymorphisms were genotyped using a sequence-based typing technique. No differences were observed regarding the frequencies of low-MBL genotypes (O/O and XA/O) and MASP2 polymorphisms between patients with SIRS and healthy controls. Interestingly, ICU patients with a noninfectious SIRS had a lower frequency for low-MBL genotypes and a higher frequency for high-MBL genotypes (A/A and A/XA) than either ICU patients with an infectious SIRS or healthy controls. The existence of low- or /high-MBL genotypes or a MASP2 polymorphism had no impact on the mortality rates of the included patients. The presence of high-MBL-producing genotypes in patients with a noninfectious insult is a risk factor for SIRS and ICU admission.


Sign in / Sign up

Export Citation Format

Share Document